Why Fluidigm's COVID-19 Saliva-Based Test Is a Huge Hit
Fluidigm made a splash with the markets on Wednesday morning after the company announced a critical update from the FDA in regards to its COVID-19 test.
Chris Lange
4 months ago

Fluidigm Stumbles on Preliminary Q3 Results
After Fluidigm announced preliminary results for its third quarter on Wednesday, investors sent the shares sharply lower.
Chris Lange
4 years ago
Last Updated: 1 year ago

Top Analyst Upgrades and Downgrades: Coca-Cola, Goldman Sachs, JPMorgan, LinkedIn, Linn Energy, Tableau, Weatherford and Many More
The top analyst upgrades, downgrades and initiations seen on Friday, February 5, include Coca-Cola, Goldman Sachs, JPMorgan, LinkedIn, Linn Energy, Tableau Software and Weatherford International.
Jon C. Ogg
4 years ago
Last Updated: 1 year ago

Fluidigm Tumbles on Weak Earnings
Shares tumbled after Fluidigm reported disappointing second-quarter financial results and lowered guidance.
Chris Lange
5 years ago
Last Updated: 5 years ago

New Cancer Detection Technique Has Enormous Potential for Life Science Stocks
A new report from Cowen makes the case that a blood test that detects evidence of cancer in the circulation could soon replace the older more traditional biopsy methods.
Lee Jackson
6 years ago
Last Updated: 6 years ago

IPO FILING: Fluidigm (FLDM)
Fluidigm, a California-based life science research device provider, has filed with the SEC to become public this morning. The offering shows a total proposed maximum aggregate price of $86,250,000....
Douglas A. McIntyre
12 years ago
Last Updated: 9 months ago